Sporadic late onset nemaline myopathy

Nizar Chahin, Duygu Selcen, Andrew G. Engel

Research output: Contribution to journalReview article

76 Citations (Scopus)

Abstract

Objective: To review the clinicopathologic features and outcome of sporadic late onset nemaline myopathy (SLONM). Background: Non-HIV-related SLONM is an uncommon disease of undefined etiology. Methods: This study is based on clinical, EMG, histochemical, immunocytochemical, and electron microscopy evaluation, and long-term follow-up of 14 patients observed at the Mayo Clinic between 1975 and 2003. Results: The disease presented between 43 and 81 years and evolved subacutely. The weakness was predominantly proximal in 11, equal proximally and distally in 3, and asymmetric in 4; dysphagia was a symptom in 6. The EMG showed myopathic features with fibrillations but the serum CK level at the time of initial examination or reevaluation was normal or below the Mayo Clinic's range of normal values for sex and age at the time of the assay. Seven patients had an associated monoclonal gammopathy. On light microscopy, the nemaline structures were best identified in 3-μm-thick frozen sections stained trichromatically or immunostained for α-actinin or myotilin. Electron microscopy done in 12 cases identified the rods in all and revealed additional structural abnormalities. Seven patients with monoclonal gammopathy were followed for 1 to 5 years; five died of respiratory failure. Five patients without monoclonal gammopathy were followed for 4 to 23 years and none died of the disease. Immunotherapy in eight patients was of uncertain benefit. Conclusions: 1) Subacutely evolving weakness after age 40, normal to low CK level, myopathic EMG with fibrillations, and often a monoclonal gammopathy are clues for the diagnosis of sporadic late onset nemaline myopathy. 2) The diagnosis is confirmed by visualizing the rods in trichrome or immunostained cryosections. 3) An associated monoclonal gammopathy heralds an unfavorable prognosis.

Original languageEnglish (US)
Pages (from-to)1158-1164
Number of pages7
JournalNeurology
Volume65
Issue number8
DOIs
StatePublished - Oct 25 2005
Externally publishedYes

Fingerprint

Nemaline Myopathies
Paraproteinemias
Electron Microscopy
Actinin
Frozen Sections
Deglutition Disorders
Respiratory Insufficiency
Immunotherapy
Microscopy
Reference Values
Light
Serum

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Sporadic late onset nemaline myopathy. / Chahin, Nizar; Selcen, Duygu; Engel, Andrew G.

In: Neurology, Vol. 65, No. 8, 25.10.2005, p. 1158-1164.

Research output: Contribution to journalReview article

Chahin, Nizar ; Selcen, Duygu ; Engel, Andrew G. / Sporadic late onset nemaline myopathy. In: Neurology. 2005 ; Vol. 65, No. 8. pp. 1158-1164.
@article{67376c1b77bb46d6993c8cb08fe9bf98,
title = "Sporadic late onset nemaline myopathy",
abstract = "Objective: To review the clinicopathologic features and outcome of sporadic late onset nemaline myopathy (SLONM). Background: Non-HIV-related SLONM is an uncommon disease of undefined etiology. Methods: This study is based on clinical, EMG, histochemical, immunocytochemical, and electron microscopy evaluation, and long-term follow-up of 14 patients observed at the Mayo Clinic between 1975 and 2003. Results: The disease presented between 43 and 81 years and evolved subacutely. The weakness was predominantly proximal in 11, equal proximally and distally in 3, and asymmetric in 4; dysphagia was a symptom in 6. The EMG showed myopathic features with fibrillations but the serum CK level at the time of initial examination or reevaluation was normal or below the Mayo Clinic's range of normal values for sex and age at the time of the assay. Seven patients had an associated monoclonal gammopathy. On light microscopy, the nemaline structures were best identified in 3-μm-thick frozen sections stained trichromatically or immunostained for α-actinin or myotilin. Electron microscopy done in 12 cases identified the rods in all and revealed additional structural abnormalities. Seven patients with monoclonal gammopathy were followed for 1 to 5 years; five died of respiratory failure. Five patients without monoclonal gammopathy were followed for 4 to 23 years and none died of the disease. Immunotherapy in eight patients was of uncertain benefit. Conclusions: 1) Subacutely evolving weakness after age 40, normal to low CK level, myopathic EMG with fibrillations, and often a monoclonal gammopathy are clues for the diagnosis of sporadic late onset nemaline myopathy. 2) The diagnosis is confirmed by visualizing the rods in trichrome or immunostained cryosections. 3) An associated monoclonal gammopathy heralds an unfavorable prognosis.",
author = "Nizar Chahin and Duygu Selcen and Engel, {Andrew G.}",
year = "2005",
month = "10",
day = "25",
doi = "10.1212/01.wnl.0000180362.90078.dc",
language = "English (US)",
volume = "65",
pages = "1158--1164",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Sporadic late onset nemaline myopathy

AU - Chahin, Nizar

AU - Selcen, Duygu

AU - Engel, Andrew G.

PY - 2005/10/25

Y1 - 2005/10/25

N2 - Objective: To review the clinicopathologic features and outcome of sporadic late onset nemaline myopathy (SLONM). Background: Non-HIV-related SLONM is an uncommon disease of undefined etiology. Methods: This study is based on clinical, EMG, histochemical, immunocytochemical, and electron microscopy evaluation, and long-term follow-up of 14 patients observed at the Mayo Clinic between 1975 and 2003. Results: The disease presented between 43 and 81 years and evolved subacutely. The weakness was predominantly proximal in 11, equal proximally and distally in 3, and asymmetric in 4; dysphagia was a symptom in 6. The EMG showed myopathic features with fibrillations but the serum CK level at the time of initial examination or reevaluation was normal or below the Mayo Clinic's range of normal values for sex and age at the time of the assay. Seven patients had an associated monoclonal gammopathy. On light microscopy, the nemaline structures were best identified in 3-μm-thick frozen sections stained trichromatically or immunostained for α-actinin or myotilin. Electron microscopy done in 12 cases identified the rods in all and revealed additional structural abnormalities. Seven patients with monoclonal gammopathy were followed for 1 to 5 years; five died of respiratory failure. Five patients without monoclonal gammopathy were followed for 4 to 23 years and none died of the disease. Immunotherapy in eight patients was of uncertain benefit. Conclusions: 1) Subacutely evolving weakness after age 40, normal to low CK level, myopathic EMG with fibrillations, and often a monoclonal gammopathy are clues for the diagnosis of sporadic late onset nemaline myopathy. 2) The diagnosis is confirmed by visualizing the rods in trichrome or immunostained cryosections. 3) An associated monoclonal gammopathy heralds an unfavorable prognosis.

AB - Objective: To review the clinicopathologic features and outcome of sporadic late onset nemaline myopathy (SLONM). Background: Non-HIV-related SLONM is an uncommon disease of undefined etiology. Methods: This study is based on clinical, EMG, histochemical, immunocytochemical, and electron microscopy evaluation, and long-term follow-up of 14 patients observed at the Mayo Clinic between 1975 and 2003. Results: The disease presented between 43 and 81 years and evolved subacutely. The weakness was predominantly proximal in 11, equal proximally and distally in 3, and asymmetric in 4; dysphagia was a symptom in 6. The EMG showed myopathic features with fibrillations but the serum CK level at the time of initial examination or reevaluation was normal or below the Mayo Clinic's range of normal values for sex and age at the time of the assay. Seven patients had an associated monoclonal gammopathy. On light microscopy, the nemaline structures were best identified in 3-μm-thick frozen sections stained trichromatically or immunostained for α-actinin or myotilin. Electron microscopy done in 12 cases identified the rods in all and revealed additional structural abnormalities. Seven patients with monoclonal gammopathy were followed for 1 to 5 years; five died of respiratory failure. Five patients without monoclonal gammopathy were followed for 4 to 23 years and none died of the disease. Immunotherapy in eight patients was of uncertain benefit. Conclusions: 1) Subacutely evolving weakness after age 40, normal to low CK level, myopathic EMG with fibrillations, and often a monoclonal gammopathy are clues for the diagnosis of sporadic late onset nemaline myopathy. 2) The diagnosis is confirmed by visualizing the rods in trichrome or immunostained cryosections. 3) An associated monoclonal gammopathy heralds an unfavorable prognosis.

UR - http://www.scopus.com/inward/record.url?scp=27144466330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144466330&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000180362.90078.dc

DO - 10.1212/01.wnl.0000180362.90078.dc

M3 - Review article

VL - 65

SP - 1158

EP - 1164

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 8

ER -